loading
Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose
Schlusskurs vom Vortag:
$2.21
Offen:
$2.21
24-Stunden-Volumen:
198.16K
Relative Volume:
0.60
Marktkapitalisierung:
$132.05M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-64.86M
KGV:
-1.9464
EPS:
-1.12
Netto-Cashflow:
$-55.66M
1W Leistung:
-0.91%
1M Leistung:
+26.01%
6M Leistung:
+101.85%
1J Leistung:
-23.37%
1-Tages-Spanne:
Value
$2.11
$2.24
1-Wochen-Bereich:
Value
$2.11
$2.46
52-Wochen-Spanne:
Value
$0.8551
$3.36

Acumen Pharmaceuticals Inc Stock (ABOS) Company Profile

Name
Firmenname
Acumen Pharmaceuticals Inc
Name
Sektor
Healthcare (1136)
Name
Branche
Biotechnology (633)
Name
Telefon
617-344-4190
Name
Adresse
1210-1220 WASHINGTON STREET, NEWTON
Name
Mitarbeiter
52
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-31
Name
Neueste SEC-Einreichungen
Name
ABOS's Discussions on Twitter

Vergleichen Sie ABOS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ABOS
Acumen Pharmaceuticals Inc
 2.18 133.87M 0 -64.86M -55.66M -1.12
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 426.00 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 642.25 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 434.07 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
 826.28 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
 186.23 40.44B 447.02M -1.18B -868.57M -6.1812

Acumen Pharmaceuticals Inc Stock (ABOS) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-06-17 Eingeleitet Citigroup Buy
2024-07-26 Eingeleitet Citigroup Buy
2023-12-12 Eingeleitet Deutsche Bank Buy
2023-07-20 Fortgesetzt BofA Securities Buy
2023-05-18 Eingeleitet Cantor Fitzgerald Overweight
2022-07-15 Eingeleitet BTIG Research Buy
2022-06-30 Eingeleitet H.C. Wainwright Buy
2022-01-21 Hochstufung BofA Securities Neutral → Buy
2021-07-26 Eingeleitet BofA Securities Neutral
2021-07-26 Eingeleitet Credit Suisse Outperform
2021-07-26 Eingeleitet Stifel Buy
2021-07-26 Eingeleitet UBS Buy
Alle ansehen

Acumen Pharmaceuticals Inc Aktie (ABOS) Neueste Nachrichten

pulisher
Nov 03, 2025

Can Acumen Pharmaceuticals Inc. rally from current levels2025 Top Decliners & Daily Risk Controlled Trade Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Acumen Pharmaceuticals Inc. stock go up soonWeekly Market Outlook & Intraday High Probability Setup Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Acumen Pharmaceuticals Inc. stock chart pattern explained2025 Trading Recap & Free Daily Entry Point Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Reversal indicators forming on Acumen Pharmaceuticals Inc. stock2025 Key Highlights & Detailed Earnings Play Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Acumen Pharmaceuticals Inc. stock recession proofPortfolio Return Report & Long-Term Safe Investment Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Using data models to predict Acumen Pharmaceuticals Inc. stock movement2025 Fundamental Recap & Safe Swing Trade Setup Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Published on: 2025-11-03 03:22:41 - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Acumen Pharmaceuticals Inc. stock attractive for passive investorsJuly 2025 Summary & Daily Stock Momentum Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will a bounce in Acumen Pharmaceuticals Inc. offer an exitCEO Change & Daily Market Momentum Tracking - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How to forecast Acumen Pharmaceuticals Inc. trends using time seriesPrice Action & Daily Stock Momentum Reports - newser.com

Nov 03, 2025
pulisher
Nov 01, 2025

Applying chart zones and confluence areas to Acumen Pharmaceuticals Inc.July 2025 Review & Consistent Income Trade Ideas - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

When is the best time to exit Acumen Pharmaceuticals Inc.Market Growth Summary & Real-Time Volume Analysis - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

How Acumen Pharmaceuticals Inc. stock performs in high volatility marketsJuly 2025 Movers & Expert Approved Momentum Ideas - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Acumen Pharmaceuticals Inc Stock Analysis and ForecastMarket Volatility Update & Free Stock Predictions and Analysis - earlytimes.in

Oct 30, 2025
pulisher
Oct 29, 2025

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Uncovering Opportunities: Beauty Health Among 3 Promising Penny Stocks - simplywall.st

Oct 29, 2025
pulisher
Oct 29, 2025

Tools to monitor Acumen Pharmaceuticals Inc. recovery probability2025 AllTime Highs & Growth Focused Entry Reports - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Published on: 2025-10-29 03:28:22 - newser.com

Oct 29, 2025
pulisher
Oct 29, 2025

Published on: 2025-10-29 02:17:26 - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Is Acumen Pharmaceuticals Inc. stock a buy in volatile markets2025 Trade Ideas & AI Forecasted Entry and Exit Points - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 27, 2025

Short Squeeze: Will Acumen Pharmaceuticals Inc. stock benefit from infrastructure spendingJuly 2025 Pullbacks & Free Expert Approved Momentum Trade Ideas - Fundação Cultural do Pará

Oct 27, 2025

Finanzdaten der Acumen Pharmaceuticals Inc-Aktie (ABOS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ähnlich wie ABOS

biotechnology RPRX
$37.30
price down icon 0.64%
biotechnology GMAB
$28.71
price up icon 0.35%
biotechnology INCY
$101.57
price up icon 8.65%
biotechnology BNTX
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
biotechnology INSM
$186.23
price down icon 1.78%
In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters
Kapitalisierung:     |  Volumen (24h):